ATE277619T1 - Verwendung von adenosin und adenosinderivaten für analgesia - Google Patents
Verwendung von adenosin und adenosinderivaten für analgesiaInfo
- Publication number
- ATE277619T1 ATE277619T1 AT97107216T AT97107216T ATE277619T1 AT E277619 T1 ATE277619 T1 AT E277619T1 AT 97107216 T AT97107216 T AT 97107216T AT 97107216 T AT97107216 T AT 97107216T AT E277619 T1 ATE277619 T1 AT E277619T1
- Authority
- AT
- Austria
- Prior art keywords
- adenosine
- analgesia
- derivatives
- composition
- cardio
- Prior art date
Links
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 title abstract 4
- 230000036592 analgesia Effects 0.000 title abstract 3
- 239000002126 C01EB10 - Adenosine Substances 0.000 title abstract 2
- 229960005305 adenosine Drugs 0.000 title abstract 2
- 150000003835 adenosine derivatives Chemical class 0.000 title 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 abstract 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 abstract 1
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 abstract 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 abstract 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 abstract 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 abstract 1
- 206010038678 Respiratory depression Diseases 0.000 abstract 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 abstract 1
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 abstract 1
- 229960003190 adenosine monophosphate Drugs 0.000 abstract 1
- 230000002802 cardiorespiratory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52152990A | 1990-05-10 | 1990-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE277619T1 true ATE277619T1 (de) | 2004-10-15 |
Family
ID=24077105
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91909913T ATE162400T1 (de) | 1990-05-10 | 1991-05-07 | Verwendung von adenosine und adenosinederivate zur anästhesie |
| AT97107216T ATE277619T1 (de) | 1990-05-10 | 1991-05-07 | Verwendung von adenosin und adenosinderivaten für analgesia |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91909913T ATE162400T1 (de) | 1990-05-10 | 1991-05-07 | Verwendung von adenosine und adenosinederivate zur anästhesie |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP0527917B2 (de) |
| JP (1) | JP3168025B2 (de) |
| AT (2) | ATE162400T1 (de) |
| AU (1) | AU653341B2 (de) |
| CA (1) | CA2082527C (de) |
| DE (2) | DE69133419T2 (de) |
| DK (1) | DK0527917T3 (de) |
| ES (1) | ES2113884T3 (de) |
| GR (1) | GR3026615T3 (de) |
| WO (1) | WO1991016903A2 (de) |
| ZA (1) | ZA913482B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6110902A (en) * | 1997-06-23 | 2000-08-29 | Moehler; Hanns | Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine |
| DE20215415U1 (de) * | 2002-10-08 | 2004-02-26 | Biotechnologie Gesellschaft Mittelhessen Mbh | Wasserlösliche Medikamentenvorstufen von Propofol |
| DE102010027595A1 (de) * | 2010-07-23 | 2012-01-26 | Helmut Vorbrüggen | Vermeidung von Ischämie- oder Degenerations-Schäden im Gehirn bei Anwendung von Adenosin-Derivaten |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1172391B (it) * | 1983-12-23 | 1987-06-18 | Polifarma Spa | Composti tirpeptidici contenenti acido piroglutaminico e triptofano,procedimentio di produzione ed applicazioni terapeutiche |
| FR2577422B1 (fr) * | 1985-02-14 | 1988-10-28 | Roussel Uclaf | Association renfermant a titre de principes actifs, un analgesique central et l'adenine ou l'adenosine ou l'un des analogues de l'adenosine |
-
1991
- 1991-05-07 DE DE69133419T patent/DE69133419T2/de not_active Revoked
- 1991-05-07 EP EP91909913A patent/EP0527917B2/de not_active Expired - Lifetime
- 1991-05-07 EP EP97107216A patent/EP0821964B1/de not_active Revoked
- 1991-05-07 DK DK91909913T patent/DK0527917T3/da active
- 1991-05-07 ES ES91909913T patent/ES2113884T3/es not_active Expired - Lifetime
- 1991-05-07 CA CA002082527A patent/CA2082527C/en not_active Expired - Fee Related
- 1991-05-07 AU AU78794/91A patent/AU653341B2/en not_active Ceased
- 1991-05-07 DE DE69128780T patent/DE69128780T2/de not_active Expired - Lifetime
- 1991-05-07 AT AT91909913T patent/ATE162400T1/de not_active IP Right Cessation
- 1991-05-07 AT AT97107216T patent/ATE277619T1/de not_active IP Right Cessation
- 1991-05-07 WO PCT/US1991/002951 patent/WO1991016903A2/en not_active Ceased
- 1991-05-08 ZA ZA913482A patent/ZA913482B/xx unknown
- 1991-05-09 JP JP13218691A patent/JP3168025B2/ja not_active Expired - Fee Related
-
1998
- 1998-04-10 GR GR980400811T patent/GR3026615T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU653341B2 (en) | 1994-09-29 |
| DE69128780T2 (de) | 1998-08-27 |
| ZA913482B (en) | 1992-02-26 |
| DE69128780D1 (de) | 1998-02-26 |
| DE69133419T2 (de) | 2005-11-17 |
| EP0527917A1 (de) | 1993-02-24 |
| EP0527917B2 (de) | 2006-08-16 |
| JP3168025B2 (ja) | 2001-05-21 |
| EP0821964B1 (de) | 2004-09-29 |
| EP0527917B1 (de) | 1998-01-21 |
| ES2113884T3 (es) | 1998-05-16 |
| CA2082527C (en) | 1998-07-28 |
| WO1991016903A2 (en) | 1991-11-14 |
| EP0821964A2 (de) | 1998-02-04 |
| AU7879491A (en) | 1991-11-27 |
| WO1991016903A3 (en) | 1992-05-14 |
| GR3026615T3 (en) | 1998-07-31 |
| EP0821964A3 (de) | 1998-09-02 |
| CA2082527A1 (en) | 1991-11-11 |
| DE69133419D1 (de) | 2004-11-04 |
| DK0527917T3 (da) | 1998-09-14 |
| JPH0665079A (ja) | 1994-03-08 |
| ATE162400T1 (de) | 1998-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3581691D1 (de) | Inositoltriphosphat enthaltende stabilisierte zusammensetzung und verfahren zur stabilisierung der zusammensetzung. | |
| ES2156852T3 (es) | Citoquina mamifera, il-11. | |
| DK0414475T3 (da) | Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier | |
| DE69308908D1 (de) | Verfahren zur Herstellung von Cytidin-Diphosphat-Cholin | |
| NO970106D0 (no) | Oppfangingsanalyser | |
| ES2035668T3 (es) | Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma. | |
| ATE92523T1 (de) | Verfahren zur abtrennung und reinigung von sialyl-transferasen. | |
| DE69110854D1 (de) | Antivirusderivate von (Phosphonmethoxy)Methoxy Purin/Pyrimidin. | |
| DE3685711D1 (de) | Anordnung zur simulation von rechnerfunktionen von grossrechenanlagen. | |
| ATE107705T1 (de) | Test zur feststellung der empfänglichkeit für dns-assoziierte krankheiten. | |
| ATE4904T1 (de) | Verfahren zur herstellung von 5'-deoxy-5fluoruridin und zwischenprodukte in diesem verfahren. | |
| DE69133419D1 (de) | Verwendung von Adenosin und Adenosinderivaten für Analgesia | |
| DE68927651D1 (de) | Derivate von Fluorphosphonat-Nukleotiden | |
| DE3768288D1 (de) | Artikulator zur simulation von unterkieferbewegungen. | |
| ATE164160T1 (de) | Verfahren zur herstellung von 2-acylamino-6- halogen-purin aus 2,9-diacylguanin | |
| DE3872888D1 (de) | Immunassay unter benutzung der mikropartikelneutralisierung. | |
| ATA238587A (de) | Anordnung zur einbringung von strahlenquellen | |
| Lloyd | Multicultural counseling: Lloyd's reply. | |
| ATE55251T1 (de) | Arzneimittel mit einem 6-substituierten adenosin als aktives bestandteil. | |
| Taylor | Can we talk | |
| Senchuk | ORGANIZATION OF INTERACTION OF STUDENTS FROM DIFFERENT COURSES IN THE PROCESS OF TEACHING MATHEMATICS FOR SOCIAL COMPETENCE | |
| IT8720225A0 (it) | Composizioni cosmetiche contenenti come principio attivo adenosin monofosfato ciclico e fosfatidil inositolo o inositolo | |
| DK553587A (da) | Acylerede 9,10-anthracendicarboxaldehyd-bis-(2-imidazolin-2-ylhydrazoner), fremgangsmaade til deres fremstilling samt deres anvendelse | |
| Votiakov et al. | Theoretical bases of the epidemiology of diseases caused by noninfectious factors | |
| ATE49693T1 (de) | Verfahren und mittel zur bekaempfung des rhombenspanners boarmia rhomboidaria. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |